Advisory Services Network, LLC Concert Pharmaceuticals, Inc. Transaction History

Advisory Services Network, LLC

  • $4.9 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$2.69 - $4.22 $35,777 - $56,126
-13,300 Closed
0 $0
Q3 2021

Nov 05, 2021
SELL
$3.17 - $4.15 $4,755 - $6,225
-1,500 Reduced 10.14%
13,300 $43,000
Q2 2021

Aug 12, 2021
BUY
$3.77 - $5.24 $3,770 - $5,240
1,000 Added 7.25%
14,800 $62,000
Q1 2021

May 24, 2021
BUY
$4.86 - $13.07 $67,068 - $180,366
13,800 New
13,800 $69,000

Others Institutions Holding CNCE

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About CONCERT PHARMACEUTICALS, INC.

CNCE Quotes by TradingView
  • Ticker CNCE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,934,600
  • Description
  • Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...
More about CNCE
Track This Portfolio

Track Advisory Services Network, LLC Portfolio

Follow Advisory Services Network, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Advisory Services Network, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email